Increasing external beam dose for T1-T2 prostate cancer: Effect on risk groups

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 4, 2006, Pages 975-981

  Thames, Howard D ^a   Kuban, Deborah A ^a   DeSilvio, Michelle L ^b   Levy, Larry B ^a   Horwitz, Eric M ^c   Kupelian, Patrick A ^d   Martinez, Alvaro A ^e   Michalski, Jeff M ^f   Pisansky, Thomas M ^g   Sandler, Howard M ^h   Shipley, William U ⁱ   Zelefsky, Michael J ^j   Zietman, Anthony L ⁱ  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e WILLIAM BEAUMONT HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

Clinical disease free survival; Multi institutional analysis; Prostate cancer; Radiotherapy; Risk groups

Indexed keywords

ABLATION; DOSIMETERS; HORMONES; PATIENT MONITORING; RECURSIVE FUNCTIONS;

CLINICAL DISEASE-FREE SURVIVAL; MULTI-INSTITUTIONAL ANALYSIS; PROSTATE CANCER; RISK GROUPS;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TREATMENT FAILURE;

HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RISK; TREATMENT FAILURE;

EID: 33745192826     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.02.043     Document Type: Article

References (15)

1. Roach M., Lu J., Pilepich M.V., et al. Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on RTOG clinical trials. Int J Radiat Oncol Biol Phys 47 (2000) 609-615
2. Pisansky T.M., Kahn M.J., Rasp G.M., et al. A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma. Cancer 79 (1997) 337-344
3. Ben-Josef E., Shamsa F., and Forman J.D. Predicting the outcome of radiotherapy for prostate carcinoma. A model-building stategy. Cancer 82 (1998) 1334-1342
4. Shipley W.U., Thames H.D., Sandler H.M., et al. Radiation therapy for clinically localized prostate cancer. A multi-institutional pooled analysis. JAMA 281 (1999) 1598-1604
5. Zagars G.K., Pollack A., and von Eschenbach A.C. Prognostic factors for clinically localized prostate carcinoma. Analysis of 938 patients irradiated in the prostate-specific antigen era. Cancer 79 (1997) 1370-1380
6. Duchesne G.M., Bloomfield D., and Wall P. Indentification of intermediate-risk prostate cancer patients treated with radiotherapy suitable for neoadjuvant hormone studies. Radiother Oncol 38 (1996) 7-12
7. Williams S.G., Millar J.L., Dally M.J., et al. What defines intermediate-risk prostate cancer? Variability in published prognostic models. Int J Radiat Oncol Biol Phys 58 (2004) 11-18
8. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response. Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
9. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study). A phase III randomised trial. Lancet 360 (2002) 103-106
10. Kuban D.A., Thames H.D., Levy L.B., et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiation in the PSA era. Int J Radiat Oncol Biol Phys 57 (2003) 915-928
11. Thames H.D., Kuban D.A., Levy L.B., et al. A comparison of alternative biochemical failure definitions based on clinical outcome of 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys 57 (2003) 929-943
12. Taylor J.M.G., Griffith M.S., and Sandler H.M. Definitions of biochemical failure in prostate cancer following radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 1212-1219
13. Bahnson R.R., Hanks G.E., Huben R.P., et al. NCCN Practice Guidelines for Prostate Cancer. Oncology 14 (2000) 111-119
14. Kattan M.W., Zelefsky M.J., Kupelian P.A., et al. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 18 (2000) 3352-3359
15. Kupelian P., Kuban D.A., Thames H.D., et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer. The combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 61 (2005) 415-419